Preservation of cortical sortilin protein levels in MCI and Alzheimer's disease

Neuroscience Letters

Volumn 471, Issue 3, 2010, Pages 129-133

  Mufson, Elliott J ^a   Wuu, Joanne ^b   Counts, Scott E ^a   Nykjaer, Anders ^c  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

Alzheimer's disease; Mild cognitive impairment; proNGF; Receptors; Sortilin

Indexed keywords

NERVE GROWTH FACTOR; NEUROTROPHIN RECEPTOR P75; PROTEIN TYROSINE KINASE A; SORTILIN;

AGED; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BRAIN LEVEL; BRAIN REGION; BRAIN TISSUE; CADAVER; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; FEMALE; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; MALE; MILD COGNITIVE IMPAIRMENT; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; TEMPORAL CORTEX; UPREGULATION;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CEREBRAL CORTEX; COGNITION DISORDERS; DISEASE PROGRESSION; FEMALE; FRONTAL LOBE; HUMANS; MALE; TEMPORAL LOBE;

EID: 76849093311     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.01.023     Document Type: Article

References (36)

1. Al-Shawi R., Hafner A., Olsen J., Chun S., Raza S., Thrasivoulou C., Lovestone S., Killick R., Simons P., and Cowen T. Neurotoxic and neurotrophic roles of proNGF and the receptor sortilin in the adult and ageing nervous system. Eur. J. Neurosci. 27 (2008) 2103-2114
2. Auld D.S., Kornecook T.J., Bastianetto S., and Quirion R. Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Prog. Neurobiol. 68 (2002) 209-245
3. Bennett D.A., Wilson R.S., Schneider J.A., Evans D.A., Beckett L.A., Aggarwal N.T., Barnes L.L., Fox J.H., and Bach J. Natural history of mild cognitive impairment in older persons. Neurology 59 (2002) 198-205
4. Braak H., and Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82 (1991) 239-259
5. Bronfman F.C., and Fainzilber M. Multi-tasking by the p75 neurotrophin receptor: sortilin things out?. EMBO Rep. 5 (2004) 867-871
6. Bruno M.A., and Cuello A.C. Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 6735-6740
7. Bruno M.A., Mufson E.J., Wuu J., and Cuello A.C. Increased matrix metalloproteinase 9 activity in mild cognitive impairment. J. Neuropathol. Exp. Neurol. (2009) 1309-1318
8. Clewes O., Fahey M.S., Tyler S.J., Watson J.J., Seok H., Catania C., Cho K., Dawbarn D., and Allen S.J. Human ProNGF: biological effects and binding profiles at TrkA, P75NTR and sortilin. J. Neurochem. 107 (2008) 1124-1135
9. Counts S.E., and Mufson E.J. The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease. J. Neuropathol. Exp. Neurol. 64 (2005) 263-272
10. Counts S.E., Nadeem M., Lad S.P., Wuu J., and Mufson E.J. Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment. J. Neuropathol. Exp. Neurol. 65 (2006) 592-601
11. Counts S.E., Nadeem M., Wuu J., Ginsberg S.D., Saragovi H.U., and Mufson E.J. Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer's disease. Ann. Neurol. 56 (2004) 520-531
12. DeKosky S.T., and Marek K. Looking backward to move forward: early detection of neurodegenerative disorders. Science 302 (2003) 830-834
13. Edwards R.H., Selby M.J., Garcia P.D., and Rutter W.J. Processing of the native nerve growth factor precursor to form biologically active nerve growth factor. J. Biol. Chem. 263 (1988) 6810-6815
14. Fahnestock M., Michalski B., Xu B., and Coughlin M.D. The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease. Mol. Cell. Neurosci. 18 (2001) 210-220
15. Fahnestock M., Yu G., Michalski B., Mathew S., Colquhoun A., Ross G.M., and Coughlin M.D. The nerve growth factor precursor proNGF exhibits neurotrophic activity but is less active than mature nerve growth factor. J. Neurochem. 89 (2004) 581-592
16. Hempstead B.L. Dissecting the diverse actions of pro- and mature neurotrophins. Curr. Alzheimer Res. 3 (2006) 19-24
17. Jansen P., Giehl K., Nyengaard J.R., Teng K., Lioubinski O., Sjoegaard S.S., Breiderhoff T., Gotthardt M., Lin F., Eilers A., Petersen C.M., Lewin G.R., Hempstead B.L., Willnow T.E., and Nykjaer A. Roles for the pro-neurotrophin receptor sortilin in neuronal development, aging and brain injury. Nat. Neurosci. 10 (2007) 1449-1457
18. Kaplan D.R., and Miller F.D. Neurobiology: a move to sort life from death. Nature 427 (2004) 798-799
19. Mamidipudi V., and Wooten M.W. Dual role for p75(NTR) signaling in survival and cell death: can intracellular mediators provide an explanation?. J. Neurosci. Res. 68 (2002) 373-384
20. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
21. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van Belle G., and Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41 (1991) 479-486
22. Mufson E.J., Chen E.Y., Cochran E.J., Beckett L.A., Bennett D.A., and Kordower J.H. Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment. Exp. Neurol. 158 (1999) 469-490
23. Mufson E.J., and Counts S.E. Basocortical cholinotrophic dysfunction during the early stages of Alzheimer's disease. In: Iqbal K., and Winblad B. (Eds). Alzheimer's Disease and Related Disorders: Clinical and Basic Research Advances (2004), Alzheimer's Association, Chicago
24. Mufson E.J., Counts S.E., Fahnestock M., and Ginsberg S.D. Cholinotrophic molecular substrates of mild cognitive impairment in the elderly. Curr. Alzheimer Res. 4 (2007) 340-350
25. Mufson E.J., Counts S.E., Perez S.E., and Ginsberg S.D. Cholinergic system during the progression of Alzheimer's disease: therapeutic implications. Expert Rev. Neurother. 8 (2008) 1703-1718
26. Mufson E.J., Ginsberg S.D., Ikonomovic M.D., and DeKosky S.T. Human cholinergic basal forebra: chemoanatomy and neurologic dysfunction. J. Chem. Neuroanat. 26 (2003) 233-242
27. Mufson E.J., and Kordower J.H. Nerve growth factor in Alzheimer's disease. In: Peter A.A., and Morrison J.H. (Eds). Cerebral Cortex (1999), Kluwer Academic/Plenum Press, New York 681-731
28. Nykjaer A., Lee R., Teng K.K., Jansen P., Madsen P., Nielsen M.S., Jacobsen C., Kliemannel M., Schwarz E., Willnow T.E., Hempstead B.L., and Petersen C.M. Sortilin is essential for proNGF-induced neuronal cell death. Nature 427 (2004) 843-848
29. Paiardini A., and Caputo V. Insights into the interaction of sortilin with proneurotrophins: a computational approach. Neuropeptides 42 (2008) 205-214
30. Peng S., Wuu J., Mufson E.J., and Fahnestock M. Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer's disease. J. Neuropathol. Exp. Neurol. 63 (2004) 641-649
31. Petersen R.C. Mild cognitive impairment as a diagnostic entity. J. Intern. Med. 256 (2004) 183-194
32. Teng H.K., Teng K.K., Lee R., Wright S., Tevar S., Almeida R.D., Kermani P., Torkin R., Chen Z.Y., Lee F.S., Kraemer R.T., Nykjaer A., and Hempstead B.L. ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J. Neurosci. 25 (2005) 5455-5463
33. Teng K.K., and Hempstead B.L. Neurotrophins and their receptors: signaling trios in complex biological systems. Cell. Mol. Life Sci. 61 (2004) 35-48
34. The National Institute on Aging Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol. Aging 18 (1997) S1-S2
35. Willnow T.E., Petersen C.M., and Nykjaer A. VPS10P-domain receptors-regulators of neuronal viability and function. Nat. Rev. Neurosci. 9 (2008) 899-909
36. Wilson R.S., Beckett L.A., Barnes L.L., Schneider J.A., Bach J., Evans D.A., and Bennett D.A. Individual differences in rates of change in cognitive abilities of older persons. Psychol. Aging 17 (2002) 179-193